logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong stocks surge | Sogou Inc. (02438.HK) surged over 11% at the close, expects to release mid-term performance tomorrow, company predicts first-half loss to narrow over 99%

date
20/08/2025
According to Securities Times app, Outdoors (02438.HK) surged over 11% in the final trading session, as of the time of publication, it rose by 10.26% to 0.86 Hong Kong dollars, with a trading volume of 22.3685 million Hong Kong dollars.
Latest
1 m ago
China Biotech (01177): Selective HER2 TKI "Zuaini" Again Obtains Breakthrough Therapy Qualification Recognition from CDE
1 m ago
China Construction Machinery Industry Association: In July, the total import and export trade of engineering machinery in China reached 55.04 billion US dollars, a year-on-year increase of 19.1%.
2 m ago
Chinese biopharmaceutical company announced that apatinib is a selective HER2 small molecule inhibitor jointly developed by Boehringer Ingelheim, which has been granted priority review and breakthrough therapy designation by the CDE for the indication of HER2-mutant advanced non-small cell lung cancer (NSCLC) in previously treated patients. In August of this year, apatinib received accelerated approval from the FDA in the United States.
2 m ago
Chinese Biopharmaceutical Company: Zopotinib Once Again Receives Breakthrough Therapy Designation from the CDE
2 m ago
Geely launches the industry's first AI cockpit, the hyper-realistic emotional intelligent entity Eva, get in the car.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.